July 24 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- FY25 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED
- FY25 REVENUE GUIDANCE MAINTAINED AT NZ$80-87 MILLION
(([email protected];))
News: ARX Aroa Biosurgery Maintains FY25 Normalised EBITDA Profit Guidance
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.005(0.95%) |
Mkt cap ! $182.7M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 54.0¢ | 53.0¢ | $4.691K | 8.777K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101129 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 13726 | 1 |
View Market Depth
| Last trade - 15.38pm 04/10/2024 (20 minute delay) ? |
| ARX (ASX) Chart |